These results suggest that elevated tumor NOS2/COX2 coexpression drives the progression of aggressive breast cancer phenotypes [10, 11]; however, mechanisms of NOS2/COX2 induction within tumors remain unclear. Here, NOS2 is linked to breast cancer.